Multimorbidity in type 1 Gaucher disease patients under miglustat therapy

被引：0

作者：

Engay, Blanca Medrano ^{[1
]}

Roy, Ana ^{[2
]}

Atutxa, Koldo ^{[3
]}

Diaz-Morant, Vicente ^{[4
]}

Garcia-Frade, Javier ^{[5
]}

Hernandez-Martin, Roberto ^{[6
]}

Luno, Elisa ^{[7
]}

Noya, Soledad ^{[8
]}

de la Serna, Javier ^{[9
]}

Villalon, Lucia ^{[10
]}

Giraldo, Pilar ^{[11
]}

机构：

[1] Inst Invest Sanitaria Aragon, Zaragoza, Spain

[2] Fdn Espanola Estudio & Terapeut Enfermedad Gauche, Zaragoza, Spain

[3] Hosp Galdakao, Bilbao, Spain

[4] Hosp Serrania Ronda, Ronda, Spain

[5] Hosp Rio Hortega, Valladolid, Spain

[6] Hosp Virgen de la Concha, Zamora, Spain

[7] Hosp Univ Cent Asturias, Oviedo, Spain

[8] Hosp Teresa Herrera, La Coruna, Spain

[9] Hosp Univ Doce Octubre, Madrid, Spain

[10] Hosp Alcorcon, Madrid, Spain

[11] Ciber Enfermedades Raras, Zaragoza, Spain

来源：

MOLECULAR GENETICS AND METABOLISM | 2018年 / 123卷 / 02期

关键词：

D O I：

10.1016/j.ymgme.2017.12.245

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

236

引用

页码：S93 / S94

页数：2

共 50 条

[41] A PROSPECTIVE STUDY OF INSULIN RESISTANCE IN GAUCHER DISEASE TYPE 1 PATIENTS WITH NORMAL WEIGHT, UNDER ENZYME REPLACEMENT THERAPY
Zimmermann, A.
Grigorescu-Sido, P.
Rossmann, H.
Lackner, K. J.
Drugan, C.
Al Khzouz, C.
Bucerzan, S.
Nascu, I.
Popp, R. A.
Zimmermann, T.
Weber, M. M.
ACTA ENDOCRINOLOGICA-BUCHAREST, 2015, 11 (02) : 180 - 188
[42] Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase/miglustat combination
Capablo, Jose L.
Franco, Rafael
de Cabezon, Alicia Saenz
Alfonso, Pilar
Pocovi, Miguel
Giraldo, Pilar
EPILEPSIA, 2007, 48 (07) : 1406 - 1408
[43] Safety and efficacy of velaglucerase alfa replacement therapy for patients with type 1 Gaucher disease
Elstein, Deborah
Zimran, Ari
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (04) : 333 - 339
[44] Bone Marrow Alteration in Patients With Type 1 Gaucher Disease on Enzyme Replacement Therapy
Lerner, D.
Simpson, W.
Hermann, G.
Balwani, M.
AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05)
[45] Pharmacogenetic study in type 1 Gaucher disease patients
Giraldo, Pilar
Almeida, Alberto
Lopez de Frutos, Laura
Medrano-Engay, Blanca
Ribate, Pilar
Andrade-Campos, Marcio
MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S52 - S52
[46] The cognitive profile of type 1 Gaucher disease patients
Biegstraaten, Marieke
Wesnes, Keith A.
Luzy, Cecile
Petakov, Milan
Mrsic, Mirando
Niederau, Claus
Giraldo, Pilar
Hughes, Derralynn
Mehta, Atul
Mengel, Karl-Eugen
Hollak, Carla E. M.
Marodi, Laszlo
van Schaik, Ivo N.
JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 (06) : 1093 - 1099
[47] ENZYME REPLACEMENT THERAPY IN GAUCHER DISEASE TYPE-1
AGGIO, MC
FERNANDEZ, V
MARCILESE, M
MEDICINA-BUENOS AIRES, 1994, 54 (02) : 140 - 144
[48] Clinical effects of miglustat on bone disease in adult type I Gaucher disease: A meta-analysis
Pastores, Gregory
Elstein, Deborah
Hrebicek, Martin
Zimram, Ari
MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S45 - S46
[49] Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study
Cox, Timothy M.
Amato, Dominick
Hollak, Carla E. M.
Luzy, Cecile
Silkey, Mariabeth
Giorgino, Ruben
Steiner, Robert D.
ORPHANET JOURNAL OF RARE DISEASES, 2012, 7
[50] Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study
Timothy M Cox
Dominick Amato
Carla EM Hollak
Cecile Luzy
Mariabeth Silkey
Ruben Giorgino
Robert D Steiner
Orphanet Journal of Rare Diseases, 7

← 1 2 3 4 5 →